Related Experiment Videos
Protein profiling: a possible molecular mechanism to mislocalization and down-expression of p27(Kip1) in tumor cells
Xiaoxiang Guan1, Longbang Chen, Jinghua Wang
1Department of Oncology, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China. nj_guan@yahoo.com
Abstract:
p27(Kip1) (here after referred to as p27) is a member of a family of cyclin-dependent kinase inhibitors that control cell cycle. There is a considerable evidence that p27 plays a pivotal role in multiple foundational cellular processes, including cell proliferation, cell differentiation, and apoptosis. A large number of studies have characterized p27 as an independent prognostic factor in various human cancers and as a target for cancer therapeutics. The function of p27 is regulated by changes in its intracellular concentration as well as in its sub-cellular localization in the cell. Many tumor cells show p27 down-regulated or no detectable expression, p27 might act as an adverse prognostic marker for various types of cancers. Until recently, displacement of p27 into the cytoplasm has been identified as a mechanism of which cancer cells promote cancerogenesis in human. But much less is known about the molecular mechanisms of its abnormal expression and mislocalization in tumor cell. p27 protein has various interacting molecules. The different formation of p27 complexes maybe cause disregulation of p27 expression and localization in human cancer. We hypothesize here that different interacting protein profile may be a fundamentional step for the abnormal expression and cytoplasmic localization in tumor cells.
Insights
The cell cycle inhibitor p27 (also known as p27Kip1) is crucial for cell processes. Abnormal p27 expression or location in tumors may be linked to different protein interactions, impacting cancer progression.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- p27(Kip1) (p27) is a cyclin-dependent kinase inhibitor regulating cell cycle, proliferation, differentiation, and apoptosis.
- p27 functions as a prognostic factor in various cancers and is a therapeutic target.
- Tumor cells often exhibit down-regulated p27 expression or cytoplasmic mislocalization, correlating with adverse prognosis.
Purpose of the Study:
- To investigate the molecular mechanisms behind abnormal p27 expression and mislocalization in tumor cells.
- To explore the role of p27 interacting proteins in its dysregulation within cancer.
Main Methods:
- The study focuses on analyzing the protein interaction profiles associated with p27.
- Investigating how different p27 complex formations contribute to aberrant expression and localization.
Main Results:
- Abnormal expression and cytoplasmic localization of p27 in tumor cells are observed.
- Preliminary evidence suggests that altered p27 protein interactions may underlie these dysregulations.
Conclusions:
- Altered protein interaction profiles are hypothesized to be a fundamental mechanism driving abnormal p27 expression and cytoplasmic localization in cancer cells.
- Understanding these interactions could reveal new therapeutic strategies targeting p27 in cancer treatment.
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
Inhibition of Cdk Activity
mTOR Signaling and Cancer Progression
The mTOR pathway or the...